Alyeska Investment Group »

Lb Pharmaceuticals shares owned by Alyeska Investment Group

Quarter-by-quarter ownership of Lb Pharmaceuticals shares owned by Alyeska Investment Group from 13F filings

Historical chart of Alyeska Investment Group investment in Lb Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Lb Pharmaceuticals held by Alyeska Investment Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Lb Pharmaceuticals by Alyeska Investment Group

Quarter filed Position value Share count Share price at filing
2025-09-30 $11M 675k 15.79

More positions owned by Alyeska Investment Group

Ishares Tr Core S&p500 Etf (IVV)
Amazon (AMZN)
Apple (AAPL)
salesforce (CRM)
Meta Platforms Cl A (META)
NVIDIA Corporation (NVDA)
Tesla Motors (TSLA)
Bank of America Corporation (BAC)
Take-Two Interactive Software (TTWO)
Microsoft Corporation (MSFT)
Coherent Corp (COHR)
Home Depot (HD)
McDonald's Corporation (MCD)
Twilio Cl A (TWLO)
Arista Networks Com Shs (ANET)

View all positions for Alyeska Investment Group

Top funds holding Lb Pharmaceuticals

Deep Track Capital
RA Capital Management
TCG Crossover Management
Commodore Capital
Logos Global Management
Jpmorgan Chase & Co
BlackRock
Balyasny Asset Management
Vivo Capital
Jennison Associates
Alyeska Investment Group
Nantahala Capital Management
Citadel Advisors
Millennium Management
Soleus Capital Management

View all funds holding Lb Pharmaceuticals